AwardedPOLGoods
Koncentrat rekombinowanego czynnika krzepnięcia VIIa wraz z dostawą do Regionalnych Centrów Krwiodawstwa i Krwiolecznictwa; znak postępowania: ZZP.ZP.411.79.2026
- Published
- Published 4 May 2026
- Deadline
- Closed 18 May 2026
Overview
The National Blood Centre procured recombinant coagulation factor VIIa concentrate for delivery to Regional Blood Donation and Transfusion Centers to ensure continuity of treatment for patients with hemophilia A and B complicated by inhibitors and acquired or congenital hemophilia A. The contract was awarded to NOVO NORDISK PHARMACEUTICAL SERVICES on 28 May 2026 for PLN 21,037,037.04.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 4 May 2026
- Deadline
- Closed
Medicinal products for the blood and blood-forming organs
Award outcome
- Awarded value
- PLN 21,037,037
- Award date
- 28 May 2026
- Contract period
- 5 June 2026 → 30 September 2026
- NOVO NORDISK PHARMACEUTICAL SERVICES
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
30 June 2026
Contract Notice
4 May 2026
Contracting authority
Narodowe Centrum Krwi
Procuring entityWarszawa, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.